FDA

Drug Approval Drug Approval Process Tobacco Products Tobacco Control Vaccine Approval Cosmetic Regulations Drug Safety E-Cigarettes Vaccine Approval Process Food Safety Oversight

3 ARTICLES

2d ago

FDA Advisory Panel Recommends Allowing Two Unproven Peptides in Pharmacies

If the FDA adopts the panel's advice, pharmacies would be able to legally prepare BPC-157 and KPV even though agency scientists say human safety and efficacy data remain inadequate.

29 ARTICLES

3d ago

Youth Tobacco Use Falls to Multi-Year Low, But Vaping and Pouches Keep Risks High

7 ARTICLES

last mo.

FDA Agrees Three‑Year Phase I/II Data Can Support uniQure’s AMT‑130 Accelerated BLA

10 ARTICLES

last mo.

FDA Adds Bemotrizinol to U.S. Sunscreen Ingredients, First New Filter in Over 20 Years

46 ARTICLES

last mo.

FDA Adds Bemotrizinol to U.S. Sunscreen Ingredients

5 ARTICLES

last mo.

Study Finds Vaping Alters 3,124 Genes and Flavors Drive Most Changes

3 ARTICLES

last mo.

FDA Clears Tempus xT CDx to Run as Tumor‑Only Diagnostic

6 ARTICLES

2mo ago

Atara Faces Investor Class Action Over FDA Rejections of EBVALLO

4 ARTICLES

2mo ago

Compass Pathways Rises on Q1 Beat as FDA Accepts Rolling Review for COMP360

5 ARTICLES

2mo ago

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

13 ARTICLES

2mo ago

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

5 ARTICLES

2mo ago

Psychedelic Therapies Gain Momentum After Trump Order

7 ARTICLES

3mo ago

FDA Elevates Ayco Farms Cantaloupe Recall to Class I Over Salmonella Risk

5 ARTICLES

3mo ago

FDA Flags Recall of 3.1 Million Store-Brand Eye Drops Over Sterility Concerns

3 ARTICLES

3mo ago

FDA Warns ImmunityBio Over Anktiva Ads as Company Adds $100 Million for Expansion

FDA

FDA Advisory Panel Recommends Allowing Two Unproven Peptides in Pharmacies

FDA Advisers Recommend BPC-157 for Pharmacy Compounding

Kalshi Opens Betting Markets for Phase 3 Drug Trials and FDA Decisions

FDA Says Metals Found in Tampons Are Not at Harmful Levels

FDA Authorizes Zyn to Market Reduced‑Risk Claims for 20 Nicotine Pouch Products

FDA Allows Zyn to Be Marketed as Lower Risk Than Cigarettes

Youth Tobacco Use Falls to Multi-Year Low, But Vaping and Pouches Keep Risks High

FDA Agrees Three‑Year Phase I/II Data Can Support uniQure’s AMT‑130 Accelerated BLA

FDA Adds Bemotrizinol to U.S. Sunscreen Ingredients, First New Filter in Over 20 Years

FDA Adds Bemotrizinol to U.S. Sunscreen Ingredients

Never miss stories about

FDA

Study Finds Vaping Alters 3,124 Genes and Flavors Drive Most Changes

FDA Clears Tempus xT CDx to Run as Tumor‑Only Diagnostic

Atara Faces Investor Class Action Over FDA Rejections of EBVALLO

Compass Pathways Rises on Q1 Beat as FDA Accepts Rolling Review for COMP360

Class Action Filed Against Atara Biotherapeutics Over Alleged Misstatements on FDA Setbacks

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

Psychedelic Therapies Gain Momentum After Trump Order

FDA Elevates Ayco Farms Cantaloupe Recall to Class I Over Salmonella Risk

FDA Flags Recall of 3.1 Million Store-Brand Eye Drops Over Sterility Concerns

FDA Warns ImmunityBio Over Anktiva Ads as Company Adds $100 Million for Expansion

Never miss stories about

FDA